Walmart stock gains after MKM analyst says buy, saying a more price discerning consumer should be a boon

Referenced Symbols

Shares of Walmart Inc. WMT, +0.86% rose 0.7% in premarket trading Friday, after the discount retail giant got a bullish boost from MKM Partners analyst Bill Kirk, who said the company is "doing the most, but getting the least credit." He raised his rating to buy and lifted his stock price target to $166 from $156. Kirk said Walmart has better inventory levels heading into the holidays, trends are accelerating while others are stagnating and is "best positioned" if the consumer becomes more price discerning given food and energy inflation. The stock had slumped 2.6% over the past three days, since Walmart reported fiscal third-quarter earnings that beat expectations, amid concerns over gross margin pressures. MKM's Kirk isn't so concerned, saying Walmart is diversifying away from food pressure, but is still gaining share against grocery peers. "Commentary on widening price gaps and not fully passing on inflation should concern other grocers but will be a boon to Walmart, particularly if the consumer becomes more value-conscious," Kirk wrote in a note to clients. Walmart's stock has slipped 4.6% over the past three months through Friday, while the Dow Jones Industrial Average DJIA, -0.17% has gained 2.8%.

Read Next

Read Next

Barclays initiates coverage of Tilray, Cronos and Canopy Growth

Barclays analyst Guarav Jain on Thursday initiated coverage of three cannabis stocks but said their businesses are limited by the relatively small size of the legal market in Canada. Barclays launched overage of Tilray undefined and Cronos undefined with an underweight rating and price targets of $10 and $5.50 respectively. Barclays also initiated coverage of Canopy Growth undefined with a price target of $14 and a equal weight rating. Canada will account for about 30% of Canopy's and Tilray's operating enterprise value, and about 40% for Cronos. "The rest of their enterprise value is attributable to optionality in the U.S. market" through alliances with U.S.-based multi-state cannabis operators, he said. "Canadian companies cannot directly invest in the US market. They are entering into structured transactions with U.S. multi-state operators that would convert into minority stakes upon U.S. federal legalization. We think the benefit of these deals accrues to the shareholders of MSOs rather than those of the Canadian companies."

More On MarketWatch

About the Author